OPKO Health Reports Third Quarter Financial and Operating Results
/
Date08 Nov 2016
Consolidated revenue increased to $298.0 million for the three months ended September 30, 2016 from $143.0 million for the comparable period of 2015. Consolidated revenue... Read More →
BioScrip Reports Third Quarter 2016 Financial Results
/
Date08 Nov 2016
DENVER, Nov. 07, 2016 (GLOBE NEWSWIRE) — BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced financial results for the third quarter 2016. For the... Read More →